H6D logo

Haleon DB:H6D Stock Report

Last Price

€9.20

Market Cap

€42.2b

7D

4.0%

1Y

21.1%

Updated

18 Dec, 2024

Data

Company Financials +

H6D Stock Overview

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. More details

H6D fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance2/6
Financial Health2/6
Dividends2/6

My Notes

Capture your thoughts, links and company narrative

Haleon plc Competitors

Price History & Performance

Summary of share price highs, lows and changes for Haleon
Historical stock prices
Current Share PriceUK£9.20
52 Week HighUK£9.40
52 Week LowUK£6.95
Beta0.24
1 Month Change7.60%
3 Month Change-0.54%
1 Year Change21.05%
3 Year Changen/a
5 Year Changen/a
Change since IPO31.43%

Recent News & Updates

Recent updates

Shareholder Returns

H6DDE Personal ProductsDE Market
7D4.0%-0.1%-1.4%
1Y21.1%-6.8%8.0%

Return vs Industry: H6D exceeded the German Personal Products industry which returned -5.9% over the past year.

Return vs Market: H6D exceeded the German Market which returned 8.1% over the past year.

Price Volatility

Is H6D's price volatile compared to industry and market?
H6D volatility
H6D Average Weekly Movement3.8%
Personal Products Industry Average Movement3.8%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.9%
10% least volatile stocks in DE Market2.5%

Stable Share Price: H6D has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: H6D's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
171525,408Brian McNamarawww.haleon.com

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues.

Haleon plc Fundamentals Summary

How do Haleon's earnings and revenue compare to its market cap?
H6D fundamental statistics
Market cap€42.18b
Earnings (TTM)€1.47b
Revenue (TTM)€13.64b

28.8x

P/E Ratio

3.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
H6D income statement (TTM)
RevenueUK£11.24b
Cost of RevenueUK£4.25b
Gross ProfitUK£6.99b
Other ExpensesUK£5.78b
EarningsUK£1.21b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 27, 2025

Earnings per share (EPS)0.13
Gross Margin62.20%
Net Profit Margin10.75%
Debt/Equity Ratio54.2%

How did H6D perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

47%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 17:05
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Haleon plc is covered by 25 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Iain SimpsonBarclays
Warren AckermanBarclays
Bethan DaviesBerenberg